ChunLing Dai

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Lapatinib has been used in combination with capecitabine or paclitaxel to treat patients with progressive HER2-overexpressing metastatic breast cancer (MBC). Unfortunately, an increased incidence of hepatotoxicity had been reported in the combinational therapy. The aim of this study was to investigate the potential mechanisms of this combinational therapy.(More)
  • 1